Indian pharmaceutical company wins antibiotic case

India's largest pharmaceutical company by sales, Ranbaxy Laboratories, said yesterday that it has won a patents infringement case brought against it by the UK's GlaxoSmithKline (GSK) in a US court.

GSK first brought the matter before the US District Court for the district of New Jersey in October 2000 against Ranbaxy's product, which was the antibiotic Cefuroxime Axetil medicine, a generic version of Glaxo SmithKline's Ceftin.